|January 29, 2015||Posted by admin under 2015, vitreo-retina|
I am quite fortunate to be able to visit the Tun Hussain Onn National Eye Institute and Hospital, Petaling Jaya, Malaysia at least twice a year. Even more fortunate is the fact that whenever I come, Dr Pall Singh FRCS, FRCOphth, a very senior Vitreo-retina specialist of the hospital, almost always has a new and interesting case to share with me.
This time (Jan 2015) when I met him, he had a case of Idiopathic Macular hole to show me. We all see macular hole cases often enough. What was new was that he had given this case an intra-vitreal injection of Ocriplasmin, a recombinant proteolytic enzyme, 4 days earlier. The vision improved from 6/24 to 6/6P. Sharing the Fundus photo, pre-injection OCT and post-Injection OCT with you. Incredible results !
The injection is quite expensive though. In Malaysia it costs about RM 17,000/- (Approx. USD 4600/-). The patient was so pleased that he got the injection in the other eye as well yesterday. Hopefully he’ll get similar results in the other eye too.
Also sharing a photograph of me with Dr Natarajan Sundaram and Dr Pall Singh….
Thanks dear Dr Pall Singh…
|January 26, 2015||2015, Article, Neuro-ophthalmology, Optics & Refraction, Sameera Irfan|
Update on Amblyopia & Strabismus Management FACTS REGARDING AMBLYOPIA : 1) Various animal studies have shown that in amblyopic eyes, the 2nd neurons in the Lateral Geniculate body and occipital cortical cells are not degenerated or dead (apoptosis), they are merely SHRUNKEN. Hence they can be made to work again. 2) Binocularly driven cells in…
|January 12, 2015||2015, Conferences, IIRSI, Information|
Scientific Programme of IIRSI 2015 at Chennai from July 4th – 5th, 2015 (Intra-Ocular Implant & Refractive Society of India) To Download the brochure of the programme please Click Here (1.6 MB pdf) On Behalf of : Prof Amar Aggarwal Dr. Agarwal’s eye hospital 19 cathedral road Chennai 600086 India (112) Like this:Like Loading… more
|December 31, 2014||2015, Admin|
Happy New Year 2015 Wishing all the members a very happy 2015. May we all share our experiences and knowledge even more in the coming year and strive to achieve academic excellence in the coming year. We owe it to ourselves and we owe it to our patients. Let us all resolve to always keep… more
|December 14, 2014||Posted by admin under 2014, Abstract, cataract, news, Pharmacology|
VANCOUVER, BC — Statin therapy significantly elevates the risk of developing cataracts severe enough to warrant surgery, suggests analyses of two distinct cohorts, one from Canada and another from the US, that add to a hazy landscape of prior studies variously concluding for or against such a risk for the widely used drugs.
For now, the possibility of such a risk from statins and its potential mechanisms should be explored in prospective trials, “especially in light of increased statin use for primary prevention of cardiovascular disease and the importance of acceptable vision in old age, when cardiovascular disease is common,” according to the report, published in the December 2014 issue of the Canadian Journal of Cardiology with lead author Dr Stephanie J Wise (University of British Columbia, Vancouver).
“However, because the relative risk is low and because cataract surgery is (more…) (296)
|December 11, 2014||Posted by admin under 2014, Abstract, journal, ophthalmology, Refractive Surgery|
Patients have superior recovery from laser-assisted in situ keratomileusis (LASIK) surgery if the LASIK flaps are made with an inverted side cut instead of a conventional side cut. Although corneal sensation is improved at year 1 with inverted side cuts, the improvement does not appear to translate into a significant improvement in subjective dry eye symptoms.
Jennifer S. Kung, MD, from the Byers Eye Institute, Stanford University School of Medicine, California, and colleagues published the results of their prospective randomized study in the December issue of Ophthalmology. The investigators randomized contralateral eyes. The comparative fellow-eye study included 120 eyes in 60 participants.
The cuts were made with two different lasers. The conventional 70° side cut was made with the 60 kHz IntraLase FS (Abbott Medical Optics), and the inverted 130° side cut was made with the 150 kHz IntraLase iFS (Abbott Medical Optics).
Patients were followed for 12 months (visits at months 1, 3, 6, and 12). Corneal sensation was measured by mean Cochet-Bonnet esthesiometry.
Preoperative corneal sensation was improved in eyes (more…) (258)
|December 10, 2014||Posted by admin under 2014, Abstract, ophthalmology|
Eye health claims made for some supplements are not supported by evidence, and the supplements could pose a risk to the user, researchers say.
“The scary thing is that the [US Food and Drug Administration] doesn’t regulate these supplements for safety or efficacy,” Jennifer J. Yong, MD, told Medscape Medical News.
Dr Yong, a resident at Yale-New Haven Hospital-Waterbury Hospital in Waterbury, Connecticut, and colleagues published a study examining supplement contents online November 20 in Ophthalmology.
Specific Formulas Are Proven
The Age-Related Eye Disease Study (AREDS), a randomized controlled trial published in 2001, showed that a specific formula of nutrients reduced the risk for vision loss from age-related macular degeneration in the intermediate and advanced stages of the disease.
The AREDS formula, made up of high doses of vitamin C, vitamin E, beta-carotene, and zinc, is patented by Bausch and Lomb.
It did not show any benefits in patients with cataracts, (more…) (349)